LATEST NEWS
Jul 10, 2023
Cytox CEO, Dr. Richard Pither, Talks About genoSCORE™-ACT Genetic Risk Test for Alzheimer's Disease on the UK's Only Dementia-Focussed Radio Show – ‘The 'D' Word With Pete Hill'
Jun 1, 2023
Cytox brings ground-breaking genetic risk test for Alzheimer's disease to the UK
Meet the Team
Dr Richard Pither
CEO
Dr Alex Gibson
Business Development Officer
Dr Paula Daunt
Project and Portfolio Manager
Dr Qian Gao
Head of Bioinformatics and Genetics
Dr Simon Flint
Clinical Diagnostics Development Lead
Dr Amanda Bowden
Marketing Consultant
Dr Ian Gilham
Chairman
Dr David Whitcombe
Non-executive Director